Enveric Biosciences, Inc.
Enveric Biosciences, Inc. (ENVB) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ENVB · as of Jun 9, 2026
Key Statistics
Explore Enveric Biosciences, Inc. Data
envb stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 4 · Buy rate: 75.0%
Competitors & Peers
envb competitorsENVB
AZTR
HEPA
INDP
JSPR
ONCOStock Performance
Full HistoryAbout Enveric Biosciences, Inc.
Enveric Biosciences, Inc. is a pharmaceutical firm focused on advancing diverse cannabinoid-based medications, primarily for use in cancer care. The company's robust product pipeline includes EV104, d…
what is enveric biosciences, inc. · envb stock overview · enveric biosciences, inc. company profile · who is enveric biosciences, inc. ceo · envb NASDAQ · enveric biosciences, inc. headquarters · enveric biosciences, inc. business segments
About Stock Overview & Key Data
Enveric Biosciences, Inc. (ENVB) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since May 4, 2015. As of the latest trading session, ENVB stock price is $1.75, with a market capitalization of $1.0M. The stock has returned -88.78% over the past 12 months and -51.79% year-to-date.
According to 4 Wall Street analysts, the consensus rating for Enveric Biosciences, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Enveric Biosciences, Inc. reported revenue of — and net income of -$12.1M. For detailed data — including Enveric Biosciences, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Enveric Biosciences, Inc. (ENVB) stock price is $1.75. The stock is traded on NASDAQ under the ticker symbol ENVB. The 52-week range is $1.66 – $17.64.